The global premium cardiovascular supplement market has evolved beyond simple mono-ingredient formulations. Modern clinical nutrition relies on multi-target cellular matrix design. The proprietary concept behind Omega Q Plus Max represents an advanced therapeutic stack designed to simultaneously target endothelial nitric oxide production, mitochondrial adenosine triphosphate (ATP) synthesis, systemic oxidative stress, and lipid membrane fluidity.
As an Original Design Manufacturer (ODM) specializing in complex bioactive matrixes, our production facilities process and standardize the key constituent ingredients that form the backbone of Omega Q Plus Max solutions:
Coenzyme Q10 (Ubiquinol / Ubiquinone)
Acts as the primary electron acceptor in mitochondrial Complexes I, II, and III. Our factory utilizes microencapsulated Ubiquinol (reduced form) possessing up to 8x higher plasma AUC (Area Under Curve) bioavailability compared to crystalline CoQ10.
Ultra-Pure Omega-3 EPA/DHA (EE & TG Forms)
Sourced via molecularly distilled cold-water marine and algae lipids. Concentrated to 80%+ purity in Re-esterified Triglyceride (rTG) form to restore myocyte cell membrane fluidity and suppress pro-inflammatory eicosanoid pathways.
L-Carnitine Tartrate & Metacell Bio-factors
Facilitates long-chain fatty acid translocation across the inner mitochondrial membrane via the carnitine palmitoyltransferase (CPT-1) shuttle, optimizing fatty acid beta-oxidation into metabolic energy.
Furthermore, integrating synergistic micro-nutrients such as Chromax® Chromium Picolinate, trans-Resveratrol, B-Vitamin co-factors (Pyridoxal-5-Phosphate, Methylcobalamin, L-5-MTHF), and specialized botanical fibrinolytic enzymes like Nattokinase establishes a comprehensive hemodynamic framework. Formulating these distinct lipids and hydrophilic actives requires strict pharmaceutical-grade contract manufacturing protocols to prevent molecular degradation caused by oxidation, thermal shock, and moisture cross-contamination.
Corporate buyers and supply chain executives managing high-volume nutraceutical SKUs face complex technical hurdles when sourcing raw materials for Omega Q Plus Max-style formulations. Due to the coexistence of lipophilic compounds (Omega-3 fatty acids, CoQ10) and hygroscopic/hydrophilic active ingredients (L-Carnitine, Resveratrol, B-Vitamins), traditional simple blending methods result in rapid phase separation, tablet swelling, softgel leakage, and premature oxidative rancidity.
| Regional Market | Primary Procurement Driver | Regulatory Thresholds | Recommended ODM Dosage Form |
|---|---|---|---|
| North America (US & Canada) | High potency EPA/DHA ratios, Clean Label non-GMO, microencapsulated non-bleeding powders. | FDA cGMP (21 CFR 111), GRAS affirmations, Proposition 65 heavy metal limits. | Enteric-coated Softgels, Liquid-filled Hard Capsules (Licaps). |
| European Union (EU) | Sustainable plant/algal sourcing, zero synthetic solvent residue, strict PAH limits. | EFSA Novel Food regulations, TOTOX < 10, ECHA REACH compliance. | Veggie Softgels (Carrageenan/Tapioca), Liposomal Powders. |
| Asia-Pacific (APAC) | Cardiovascular anti-aging, combined Nattokinase enzymatic activity, small pill sizes. | NMPA health food filings, TGA TGO 101 standards, Halal & Kosher. | Seamless Micro-Spherules, Dual-chamber Liquid Capsules. |
| Latin America (LATAM) | Cost-effective bulk softgel premixes, ambient shelf-life stability in high humidity. | ANVISA regulatory registration, strict microbial limits. | Nitrogen-flushed Blister-packaged Softgels. |
To mitigate Total Cost of Ownership (TCO) and avoid costly batch recalls, procurement teams require factories capable of offering verified batch-to-batch consistency. Our factory ecosystem integrates automated High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS/MS), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to guarantee zero heavy metals, zero solvent residues, and full analytical compliance.
Nitrogen-Purged Emulsification
During multi-phase compounding, oxygen exposure is reduced to < 0.5% using continuous blanket nitrogen injection. This preserves fragile double bonds in EPA and DHA, keeping Total Oxidation (TOTOX) levels well below global pharmacopeia limits.
Fluid-Bed Microencapsulation
Hydrophobic oils and CoQ10 are converted into free-flowing, cold-water-dispersible powders via starch-matrix or lipid-shell microencapsulation. This enables seamless tablet compression and stick-pack sachet filling without oil leaching.
Real-Time In-Line NIR Process Control
Our factory floors utilize Near-Infrared Spectrometry (NIR) sensors integrated directly into the batch homogenizers, providing real-time data on homogeny, moisture levels, and active payload uniformity prior to encapsulation.
rTG Lipid & Ubiquinol Softgels
Standard pharmaceutical gelatin or tapioca softgel encapsulation with high-potency re-esterified triglycerides and reduced CoQ10.
Dry Liposomal Nano-Powders
Phospholipid-complexed dry powders offering high gastric-acid resistance, target lymphatic absorption, and zero burp-back profile.
Fermentation EPA/DHA & C15:0
Precision fermentation of single-cell marine microalgae producing pure EPA/DHA paired with Pentadecanoic Acid (C15:0) for enhanced membrane integrity.
Targeted Organelle Delivery
Mitochondria-targeted peptide carrier conjugates that actively cross cell membranes to deliver CoQ10 directly into the inner mitochondrial matrix.
Advanced Cardio-Vascular Max
Core Matrix: rTG EPA/DHA (600mg) + Ubiquinol CoQ10 (100mg) + Nattokinase (2,000 FU) + L-Carnitine (250mg).
Target Benefit: Arterial elasticity, circulation improvement, fibrin degradation, and endothelial nitric oxide support.
Metabolic & Glycemic Energy Synergy
Core Matrix: Microencapsulated CoQ10 (150mg) + Chromax® Chromium Picolinate (200mcg) + Trans-Resveratrol (100mg) + Alpha Lipoic Acid.
Target Benefit: Mitochondrial biogenesis, insulin sensitivity restoration, and protection against advanced glycation end-products (AGEs).
Cellular Longevity & Anti-Fatigue
Core Matrix: Algal EPA/DHA (Pure Vegan) + Pentadecanoic Acid C15:0 + PQQ (Pyrroloquinoline Quinone) + Active B-Complex.
Target Benefit: Cell membrane fortification, NAD+ pathway support, fatigue resistance, and systemic cellular rejuvenation.
Exporting complex lipid and bioactive formulations requires strict adherence to international food safety and pharmaceutical laws. Our ODM production base operates under ISO 22000, FSSC 22000, NSF cGMP, Halal, and Kosher certifications. Every batch manufactured is backed by full analytical documentation:
Physicochemical & Assay Testing
Assigned potency testing via HPLC and UV-Vis spectrographs ensures that 100% label claim is maintained throughout the 24-month or 36-month shelf life.
Oxidation Profile Validation
Continuous testing of Peroxide Value (PV < 2.0 meq/kg), Anisidine Value (AV < 8.0), and calculated Total Oxidation (TOTOX < 10) for all marine and algal oil batches.
Contaminant & Residue Screening
ICP-MS analysis verifying Lead (<0.1 ppm), Arsenic (<0.1 ppm), Cadmium (<0.1 ppm), and Mercury (<0.01 ppm), alongside 400+ pesticide residue screens via GC-MS/MS.
What makes your factory's Omega Q Plus Max ODM formulation superior in bioavailability?
How does your factory prevent cross-degradation between CoQ10, L-Carnitine, and Omega-3 oils?
What delivery forms are available for custom ODM manufacturing?
What are the Minimum Order Quantities (MOQ) and production lead times for custom formulations?
Can your factory accommodate vegan and plant-based Omega-3 requirements?
Which regulatory documentation is provided with bulk exports?
